ACUTE AND SUBCHRONIC TOXICITY OF GRANULES OF TIEN LIET THANH GIAI BY EXPERIMENTAL TRIAL

2015 ◽  
pp. 24-27
Author(s):  
Thi Phuong Quynh Nguyen ◽  
Thi Ngoc Thanh Vu ◽  
Thi Tan Nguyen
Keyword(s):  
Body Weight ◽  
Acute Toxicity ◽  
Subchronic Toxicity ◽  
Hematopoietic System ◽  
Experimental Trial ◽  
Daily Dose ◽  
Liver And Kidney ◽  
Wilcoxon Method

Objectives: Study on the acute and subchronic toxicity of granules of Tien liet thanh giai (TLTG). Methods: Define LD50 of granules of TLTG in the mice by Litchfield – Wilcoxon method. Subchronic toxicity: TLTG was been given orally to rabbit with the daily dose of 1,2g and 3,6g/kg body weight for 3 successive months. The measurements of the liver, kidney and blood were followed before, during and after the trial. Results: There was no mice died during 72 hours and there was no toxic signs observed in the mice after 7 days observed. There was no changes in parameters of the liver and kidney, and hematopoietic system. Conclusion: LD50 can not be defined in the mice. There was no subchronic toxicity in rabbit with the daily dose of 1,2g and 3,6g/kg body weight. Keywords: Acute toxicity, subchronic toxicity, experiment.

Evaluation of acute and subchronic toxicity of “Tran Chau Nguu Hoang Hoan” in experimental animals

2021 ◽  
Vol 148 (12) ◽  
pp. 38-47
Author(s):  
Tran Thai Ha ◽  
Pham Thi Van Anh ◽  
Dao Xuan Tinh ◽  
Dinh Thi Thu Hang
Keyword(s):  
Acute Toxicity ◽  
Oral Administration ◽  
Toxicity Test ◽  
Acute Toxicity Test ◽  
Subchronic Toxicity ◽  
Experimental Animals ◽  
Microscopic Images ◽  
Renal Functions ◽  
Liver And Kidney ◽  
Oral Doses

“Tran chau nguu hoang hoan” was prepared from 12 herbal ingredients. So far, the safety of this product, has not been reported yet. Thus, this study aimed to evaluate the acute and subchronic toxicity of “Tran chau nguu hoang hoan” through oral administration in experimental animals. The acute toxicity was determined by the method of Litchfield Wilcoxon in mice at the doses of 2.42 g/kg b.w/day to 6.04 g/kg b.w/day. The subchronic toxicity was evaluated followed the Guideline of WHO and OECD in rats with oral doses of 58.0 mg/kg b.w/day and 174.0 mg/kg b.w/day for 12 consecutive weeks. As a result, in the course of the acute toxicity test, the mice showed no abnormal sign or death. In terms of the subchonic toxicity test, hematological indexes, hepato-renal functions and microscopic images of liver and kidney were unchanged. In conclusion, “Tran chau nguu hoang hoan” does not appear to produce acute and subchronic toxicities in mice and rats.

scholarly journals Acute and subchronic oral toxicities of “Da day An Chau” tablets in experimental animals

2021 ◽  
Vol 141 (5) ◽  
pp. 1-9
Author(s):  
Tran Thanh Tung ◽  
Dao Viet Hoang ◽  
Pham Thi Van Anh ◽  
Dang Thi Thu Hien
Keyword(s):  
Body Weight ◽  
Acute Toxicity ◽  
World Health Organization ◽  
Biochemical Parameters ◽  
Maximum Dose ◽  
Toxicity Study ◽  
World Health ◽  
Subchronic Toxicity ◽  
Experimental Animals ◽  
Health Organization

In this study, the toxicities of “Da day An Chau” tablets (DDAC) were assessed on experimental animals. To evaluate the acute toxicity on Swiss mice according to World Health Organization Guidance and to determine LD50 refer to the method of Litchfield – Wilcoxon. The subchronic toxicity study of DDAC at two doses (0.58 g/kg/day and 1.74 g/kg/day) was conducted in rats for four consecutive weeks. Evaluation of general conditions and weight of rats during the study period. Rat’s blood was taken for hematological and biochemical evaluations. The livers and kidneys microscopes were evaluated at the end of the experiment. The result revealed that mice were taken up to a maximum dose of 25.71 g/kg with no symptoms of acute toxicity; LD50 of DDAC has not been determined. At two doses, the subchronic toxicity study did not change rats’ body weight, hematological, biochemical parameters, and microscopic of the livers and kidneys during the study period.

scholarly journals ACUTE TOXICITY OF Β-KITIN EXTRACTED FROM THE SHELL OF BLUE SWIMMING CRAB (PORTUNUS PELAGICUS LINN.)

2021 ◽  
pp. 136-140
Author(s):  
RENNY AMELIA ◽  
NYI MEKAR SAPTARINI ◽  
JUTTI LEVITA ◽  
SRI ADI SUMIWI
Keyword(s):  
Body Weight ◽  
Acute Toxicity ◽  
Organ Weight ◽  
Control Group ◽  
Acute Toxicity Test ◽  
Organ Function ◽  
Normal Behaviour ◽  
Portunus Pelagicus ◽  
Acute Toxicity Study ◽  
Liver And Kidney

Objective: This work aimed to study the acute toxicity of β-chitin extracted from crab shells in Bal b/c mice. Method: The acute toxicity test was performed by following the OECD guidelines. Female mice were given single or divided doses of β-chitin (maximum 24 h) with doses of 500, 1000, 2000, 4000, and 6000 mg/kg of BW. Observations were made for 14 d, including behaviour, body weight, organ weight, and histopathology of vital organs (stomach, heart, liver, kidney, and lung). Results: During 14 d, no deaths and no abnormalities in behaviour, bodyweight or organ weight were observed. Qualitative histopathological observations at the highest dose showed abnormalities of the liver and kidney compared to those of the control group. Nevertheless, the abnormalities did not affect the organ function. Conclusion: This acute toxicity study reveals that β-chitin up to a dose of 6000 mg/kg of BW is not toxic, as proved by the normal behaviour, body weight, and vital organ weight of the animals. Further chronic toxicities study is needed to confirm its safety.

scholarly journals Acute and Sub-chronic Toxicity Studies on Methanol Stem Bark Extract of Frankincense Tree (Boswellia dalzielii) and Leaves Extract of Kenaf (Hibiscus cannabinus)

2021 ◽  
pp. 33-38
Author(s):  
S. Salihu ◽  
C. A. Otitolaiye ◽  
M. U. Hizbullah
Keyword(s):  
Body Weight ◽  
Acute Toxicity ◽  
Chronic Toxicity ◽  
Stem Bark ◽  
Toxicity Study ◽  
Bark Extract ◽  
Albino Rats ◽  
Liver And Kidney ◽  
Stem Bark Extract ◽  
Oral Acute Toxicity

Aim: Frankincense tree (Boswellia dalzielii) and Kenaf (H. cannabinus) are plants abundantly found in north-western Nigeria. These plants are very popular among the locals as potent sources of ethno medicine. The present study investigates the oral acute toxicity potentials of methanolic stem bark extract of frankincense tree and Kenaf leaves, as well as sub-chronic toxicity potentials of the plants extracts on the kidney and liver of Albino rats. Study Design: Laboratory-experimental design was used for this study. Place and Duration of Study: This study was carried out between September 2019 and November 2019 at Biochemistry laboratory, Sokoto State University, Sokoto, Nigeria. Methodology: For the oral acute toxicity study, the revised “Up and Down” test (Limit Dose Test) was used to determine the LD50 of the extracts. For sub-chronic toxicity study, twenty albino rats were used for each plant, and were divided into four groups of five animals each. Group I (control), Group II (received 200 mg extract/kg body weight), Group III (received 400 mg extract/kg body weight) and Group IV (received 800 mg extract/kg body weight). All administrations were given orally for 28 days. Liver and kidney markers were determined using standard methods. Result: The oral acute toxicity test of the plant extracts at 3000 mg/kg body weight showed no mortality for 24 hours and subsequent 14days of administration. LD50 for both plants is therefore greater than 3000 mg/kg. The result shows no significant differences (p > 0.05) on liver and kidney function biomarkers investigated when Group II, III and IV are compared with control. Conclusion: This suggests that Frankincense stem bark and kenaf leaves extracts may be safe in rats at doses less than or equal 3000 mg/kg.

The evaluation of acute and subchronic toxicities of An Phu Khang capsules in experimental animals

2021 ◽  
Vol 148 (12) ◽  
pp. 86-95
Author(s):  
Ha Thi Yen ◽  
Tran Thanh Tung ◽  
Dang Thi Thu Hien
Keyword(s):  
Acute Toxicity ◽  
Oral Administration ◽  
Wistar Rats ◽  
Hematological Parameters ◽  
Control Group ◽  
Subchronic Toxicity ◽  
Experimental Animals ◽  
Swiss Mice ◽  
Human Dose ◽  
Liver And Kidney

The purpose of this research was to evaluate the acute and subchronic toxicities of An Phu Khang capsules through oral administration in experimental animals. The acute toxicity was determined by the method of Litchfield Wilcoxon in Swiss mice. The subchronic toxicity was evaluated by the recommendation of WHO in Wistar rats at these doses of 0.54 g/kg b.w/day (equal to recommended human dose) and 1.62 g/kg b.w/day (3 times as high as recommended human dose) in 4 consecutive weeks. As a result, An Phu Khang capsules at the highest dose used for mice (36.29 g/kg b.w) did not show acute toxicity in mice. In terms of the subchronic toxicity test, after oral administration of An Phu Khang capsules, hematological parameters, hepato-renal functions, and microscopic images of liver and kidney at both doses were unchanged compared with the control group. In conclusion, An Phu Khang with both doses 0.54 g/kg b.w/day and 1.62 g/kg b.w/day did not produce acute and subchronic toxicities in Swiss mice and Wistar rats.

scholarly journals Acute Toxicity Study of Anvillea Radiata Aqueous Extract in Albino Rats

2020 ◽  
Vol 10 (5) ◽  
pp. 126-130
Author(s):  
Amal BELAKREDAR ◽  
Kadda HACHEM ◽  
Farouk BOUDOU ◽  
Yasmina BENABDESSLEM ◽  
Aicha MEGHERBI
Keyword(s):  
Body Weight ◽  
Weight Gain ◽  
Acute Toxicity ◽  
Aqueous Extract ◽  
Biochemical Parameters ◽  
Body Weight Gain ◽  
Female Rats ◽  
Albino Rats ◽  
Renal Tubules ◽  
Liver And Kidney

Despite the popular use and the biological effects of Anvillea radiata, there are no studies or data about its safety. The aim of the present study was to assess the acute toxicity of A. radiata aqueous extract in vivo. A single dose of 0.25, 0.5, 1, 1.5, 2.5 or 5 g/kg was administered to female rats by gavage. Body weight gain, general behavior and mortality were monitored for up to 2 weeks. Selected biochemical parameters, aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN) and blood creatinine levels were determined, as well as, liver and kidney histology. Results showed no significant changes in body weight gain and organ indexes with no mortality during the experimentation period. A significant increase in AST and ALT levels were observed in 2.5 and 5 g/kg extract treated groups, and a significant decrease in BUN and creatinine levels in 1, 1.5, 2.5 or 5g/kg extract treated groups compared to control. Microscope examination of liver sections showed several anomalies in rats exposed to high concentrations (1.5, 2.5 and 5 g/kg) including fatty changes, glycogen accumulation and ballooning degeneration hepatocytes. Renal parenchyma anomalies were also observed in rats exposed to 2.5 and 5g / kg of plant extract including shrunken renal corpuscles with marked hypo-cellularity and atrophied glomeruli, large interstitial space, and renal tubules with dilated lumina which appear completely distorted. From this study, it can be concluded that Anvillea radiata aqueous extract at high concentration (higher than 1 g /kg b.w.) may be toxic and affect sensitive organs function such liver and kidney. Keywords: Anvillea radiata, Acute toxicity, Biochemical parameters, Histology.

scholarly journals Evaluation of acute and subchronic toxicities of “Phuong Dong Dai Trang” tablets in experimental animals

2021 ◽  
Vol 141 (5) ◽  
pp. 29-38
Author(s):  
Tran Thanh Tung ◽  
Dau Thuy Duong ◽  
Pham Thi Thuy Minh ◽  
Nguyen Thu Hien ◽  
Dinh Thi Thu Hang
Keyword(s):  
Acute Toxicity ◽  
Oral Administration ◽  
Wistar Rats ◽  
Hematological Parameters ◽  
Control Group ◽  
Subchronic Toxicity ◽  
Swiss Mice ◽  
Human Dose ◽  
Liver And Kidney ◽  
Oral Doses

The study aimed to evaluate the acute and subchronic toxicities of “Phuong Dong Dai Trang” tablets through oral administration using experimental animal models. Acute toxicity in Swiss mice was determined using the Litchfield Wilcoxon method. The subchronic toxicity in Wistar rats was evaluated according to WHO and OECD’s recommendation with oral doses of 4.68 g/kg/day (equivalent to recommended human dose) and 14.04 g/kg/day (3 times the recommended human dose) for 4 consecutive weeks. In terms of acute toxicity, “Phuong Dong Dai Trang” tablets did not express acute toxicity in mice at the highest dose used (232.14 g materials/kg). In terms of the subchronic toxicity, after oral administration of “Phuong Dong Dai Trang” tablets, hematological parameters, hepato - renal functions, and microscopic images of liver and kidney were unchanged in the treatment group compared to the control group. In conclusion, “Phuong Dong Dai Trang” tablets did not produce acute and subchronic toxicities in Swiss mice and Wistar rats.

scholarly journals Acute and Subchronic Toxicity Studies of Aqueous Extract of Desmodium adscendens (Sw) DC

2017 ◽  
Vol 22 (4) ◽  
pp. 753-759 ◽  
Author(s):  
Osbourne Quaye ◽  
Precious Cramer ◽  
Mark Ofosuhene ◽  
Laud K. N. Okine ◽  
Alexander K. Nyarko
Keyword(s):  
Body Weight ◽  
Drug Interaction ◽  
Acute Toxicity ◽  
Plant Extract ◽  
Wistar Rats ◽  
Leaf Extract ◽  
Lethal Dose ◽  
Subchronic Toxicity ◽  
Toxicity Studies ◽  
Toxicity Effects

Extracts of Desmodium adscendens (Sw) DC are used for the treatment of various diseases but limited toxicological evaluations have been done on the medicinal plant. This study investigates toxicity effects of the leave extract of D adscendens, and the possibility of drug-drug interaction of the plant extract when co-administered with other drugs. Oral administrations of leaf extract of D adscendens to white Wistar rats in an acute toxicity studies allowed the estimation of an LD50 (median lethal dose) value of 1122 mg/kg body weight. In a subchronic toxicity studies, the plant extract caused a decrease in zoxazolamine paralysis time and prevented thiopentone from causing sleep in test animals compared to controls. Overall, the results are consistent with the plant extract being safe at the doses administered in humans. However, the induction of the CYP enzymes is an indication of a possible drug interaction when the plant extract is co-administered with other drugs.

Acute and subacute toxicity assessment of Madhulai Manappagu (Siddha herbal syrup formulation) in animal model

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Meenakshi Sundaram Malayappan ◽  
Gayathri Natarajan ◽  
Logamanian Mockaiyathevar ◽  
Meenakumari Ramasamy
Keyword(s):  
Body Weight ◽  
Acute Toxicity ◽  
Oral Route ◽  
Toxicity Assessment ◽  
Toxicity Study ◽  
Female Rats ◽  
Albino Rats ◽  
Oral Toxicity ◽  
Gross Pathology ◽  
Toxicity Studies

Abstract Objectives Madhulai Manappagu – a well-known sastric and widely prescribed Siddha herbal syrup formulation indicated for treating Veluppu Noi (Anaemia especially Iron deficiency Anaemia) has been in day today practice in Tamil Nadu for a quite longer decades. The syrup is a herbal preparation which has a sweet pleasant odour and a palatable taste, contain the juice of pomegranate (Punica granatum L.) as the main ingredient. Though the formulation is a fruit juice, the safety profile of the syrup is not established and is being marketed without toxicological evaluation. The study is aimed at ascertaining the acute and sub-acute toxicity assessment of Madhulai Manappagu in Wistar Albino rats. Methods The acute and sub-acute (28day repeated oral) toxicity studies were performed as per the guidelines mentioned in the Organization for Economic Cooperation and Development (OECD) 423 (adopted on December 2001) and TG 407 (adopted on October 2008) with slight modifications respectively. For acute toxicity study, three female rats were randomly selected as control; three female rats were randomly selected and were administered a single dose of 5,000 mg/kg body weight per oral route. For sub-acute (28day repeated oral) toxicity studies, three doses of test drug MM of 500 mg/kg/day (low dose), 750 mg/kg/day (intermittent dose) and 1,000 mg/kg/day (high dose) were selected for administration. Both sexes of Wistar Albino rats were randomized into four groups of 10 animals each (five males, five females). Group I was kept as control group. Group II, III and IV served as low, intermittent and high doses of MM respectively. Animals were observed for mortality, morbidity, body weight changes, feed and water intake. Haematology, clinical biochemistry, electrolytes, gross pathology, relative organ weight and histopathological examination were performed. Results In the acute toxicity study, rats showed no toxicological signs on behavior, gross pathology and body weight of rats when treated with a single dose of 5,000 mg/kg body weight per oral route. In the subacute (28 days repeated oral) toxicity study, rats have showed no significant changes on behavior, gross pathology, body weight, and hematological and biochemical parameters when treated with Madhulai Manappagu in three different doses. Conclusions The toxicity studies which include both acute and 28 days repeated (subacute) oral toxicity studies, revealed no observed adverse effect level (NOAEL) of Madhulai Manappagu in animals. Thus the safety of the drug in human usage was ensured.

scholarly journals Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved

Obesity Facts ◽  
2021 ◽  
pp. 1-7
Author(s):  
Liesbet Trenson ◽  
Sander Trenson ◽  
Falco van Nes ◽  
Carolien Moyson ◽  
Matthias Lannoo ◽  
...  
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Weight Management ◽  
Real World ◽  
Subcutaneous Administration ◽  
Maximum Tolerated Dose ◽  
Significant Weight Loss ◽  
Additional Weight ◽  
Obstructive Sleep ◽  
Daily Dose

<b><i>Introduction:</i></b> Obesity is a global health challenge, and pharmacologic options are emerging. Once daily subcutaneous administration of 3 mg liraglutide, a glucagon like peptide-1 analogue, has been shown to induce weight loss in clinical trials, but real-world effectiveness data are scarce. <b><i>Methods:</i></b> It is a single-centre retrospective cohort study of patients who were prescribed liraglutide on top of lifestyle adaptations after multidisciplinary evaluation. In Belgium, liraglutide is only indicated for weight management if the BMI is &#x3e;30 kg/m<sup>2</sup> or ≥27 kg/m<sup>2</sup> with comorbidities such as dysglycaemia, dyslipidaemia, hypertension, or obstructive sleep apnoea. No indication is covered by the compulsory health care insurance. Liraglutide was started at 0.6 mg/day and uptitrated weekly until 3 mg/day or the maximum tolerated dose. Treatment status and body weight were evaluated at the 4-month routine visit. <b><i>Results:</i></b> Between June 2016 and January 2020, liraglutide was prescribed to 115 patients (77% female), with a median age of 47 (IQR 37.7–54.0) years, a median body weight of 98.4 (IQR 90.0–112.2) kg, a BMI of 34.8 (IQR 32.2–37.4) kg/m<sup>2</sup>, and an HbA1c level of 5.6%. Five (4%) patients did not actually initiate treatment, 9 (8%) stopped treatment, and 8 (7%) were lost to follow-up. At the 4-month visit, the median body weight had decreased significantly by 9.2% to 90.8 (IQR 82.0–103.5) kg (<i>p</i> &#x3c; 0.001). Patients using 3.0 mg/day (<i>n</i> = 60) had lost 8.0 (IQR 5.8–10.4) kg. The weight loss was similar (<i>p</i> = 0.9622) in patients that used a lower daily dose because of intolerance: 7.4 (IQR 6.2–9.6) kg for 1.2 mg (<i>n</i> = 3), 7.8 (IQR 4.1–7.8) kg for 1.8 mg (<i>n</i> = 16), and 9.0 (IQR 4.8–10.7) kg for 2.4 mg/day (<i>n</i> = 14). Weight loss was minimal if liraglutide treatment was not started or stopped prematurely (median 3.0 [IQR 0.3–4.8] kg, <i>p</i> &#x3c; 0.001, vs. on treatment). Further analysis showed an additional weight reduction of 1.8 kg in the patients that had started metformin &#x3c;3 months before the start of liraglutide (<i>p</i> &#x3c; 0.001). The main reasons for liraglutide discontinuation were gastrointestinal complaints (<i>n</i> = 5/9) and drug cost (<i>n</i> = 2/9). <b><i>Conclusion:</i></b> In this selected group of patients, the majority complied with liraglutide treatment over the initial 4-month period and achieved a significant weight loss, irrespective of the maximally tolerated maintenance dose. Addition of metformin induced a small but significant additional weight loss.

Sign in / Sign up

Export Citation Format

Share Document